Hong Seng’s unit to conduct Covid-19 test for VTL on-arrivals


Hong Seng Bhd’s unit Neogenix Sdn Bhd has been appointed by the Johor state to provide medical screening of Covid-19 tests for on-arrival for ‘Vaccinated Travel Lane’ (VTL) at all domestics international gateways and towards the reopening of the border to daily travellers or Daily Commuting Arrangement.

In a filing to Bursa Malaysia the company said the company said it received a letter of appointment (LOA) from Menteri Besar Johor and that the LOA is for a period of 2 years and with the option for renewal if required.

“The Board envisages that the LOA is expected to contribute positively to the earnings of Hong Seng Group as well as the earnings per share of Hong Seng over the duration of the LOA,” the company added.

Neogenix Sdn Bhd is a 60% owned subsidiary of HS Bio Sdn Bhd which is a wholly-owned subsidiary of Hong Seng.

Malaysia and Singapore reopened the borders on Nov 29, allowing only vaccinated travellers to cross after nearly two years of border closure due to the COVID-19 pandemic.

Travellers must test negative for COVID-19 before departure, and also take an on-arrival test.